fluorodeoxyglucose f18 has been researched along with Arrhythmogenic Right Ventricular Dysplasia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashworth, M; Elliott, P; Guttmann, O; Menezes, L; Mohiddin, SA; Protonotarios, A; Savvatis, K; Sekhri, N; Stephenson, E; Syrris, P; Wicks, E | 1 |
| Broadhurst, PA; Choo, WK; Dawson, DK; Dempsey, OJ; Denison, AR; Miller, DR | 1 |
| Bradlow, WM; Myerson, SG; Newton, JD; Rajappan, K; Ratnatunga, C | 1 |
3 other study(ies) available for fluorodeoxyglucose f18 and Arrhythmogenic Right Ventricular Dysplasia
| Article | Year |
|---|---|
Prevalence of
Topics: Adult; Arrhythmogenic Right Ventricular Dysplasia; Biopsy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocarditis; Myocardium; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Survival Rate; United Kingdom | 2019 |
Cardiac sarcoid or arrhythmogenic right ventricular cardiomyopathy: a role for positron emission tomography (PET)?
Topics: Arrhythmogenic Right Ventricular Dysplasia; Cardiomyopathies; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Sarcoidosis | 2013 |
PET-diagnosed lead infection in ARVC.
Topics: Adult; Arrhythmogenic Right Ventricular Dysplasia; Defibrillators, Implantable; Diagnosis, Differential; Echocardiography, Transesophageal; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Staphylococcal Infections | 2012 |